Listing Page

Category: Strategic Sourcing

Unlocking Oral Bioavailability: How SNAC Is Transforming Drug Delivery of Biologics
The FDA approval of an oral semaglutide (Rybelsus®) marked a turning point for oral bioavailability,...
Read More >
Charting New Territory: Pharma's API Sourcing Challenges
The global shift in active pharmaceutical ingredient (API) sourcing from China to India is redefining...
Read More >
The Differences Between Purchasing Tactics & Procurement Strategy
Drawing on almost two decades of experience, I have learned some fundamental differences between Purchasing...
Read More >
Reshoring Early-Stage Pharma
The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...
Read More >
Can the U.S. Stop Buying Drugs from China?
The SARS-CoV-2 pandemic has drawn significant attention to just how much US pharmaceutical manufacturers...
Read More >
A Look at Reshoring Drug Manufacturing: A Q&A With LGM Pharma’s Hamilton Lenox
When SARS-CoV-2 arrived on American shores this Spring, concerns about overextended drug supply chains...
Read More >
1 2